Overview

Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
0
Participant gender:
All
Summary
In this study investigators are studying the effects of a drug called ketamine on the symptoms of Obsessive-compulsive disorder (OCD).
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Ketamine
Criteria
Inclusion Criteria:

- Age 18-55

- Physically healthy and not currently pregnant

- Primary Diagnosis of OCD

- Sufficient severity of symptoms

- Able to provide consent

Exclusion Criteria:

- Psychiatric conditions that make participation unsafe

- Currently on psychotropic medication

- Medical conditions that make participation unsafe

- Allergy to ketamine

- Any metal in the body